ijms-logo

Journal Browser

Journal Browser

Tumor Microenvironment in Colorectal Cancer (Volume 2)

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 4832

Special Issue Editor


E-Mail Website
Guest Editor
1. Medical Oncology Department, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá University, 28034 Madrid, Spain
2. Centro de Investigación Biomédica en Red de Cancer (CIBERONC), 28029 Madrid, Spain
Interests: tumor microenvironment; colorectal cancer; cancer-associated fibroblasts; exosomes; migration and invasion; tumor biomarkers
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue follows the publication of the first volume “Tumor Microenvironment in Colorectal Cancer”, which presented nine papers.

Experimental studies and analyses of clinical material have convincingly demonstrated that colorectal cancer initiation, growth, and progression do not depend exclusively on cell-autonomous properties of cancer cells themselves but are also deeply influenced by the local microenvironment. The stromal elements of tumors consist of a variety of non-epithelial cell types and their interactions which involve reciprocal paracrine signaling, including growth factors, exosomes, and extracellular matrix components.

Extracellular matrix, blood vessels, immune cells, and fibroblasts are the main components of the tumor microenvironment. Fibroblasts are one of the most abundant and active cell types of the tumor microenvironment. Fibroblast-like cells, usually named as cancer-associated fibroblasts (CAFs), regulate many aspects of tumorigenesis and can exert tumor-suppressing and tumor-promoting effects, involving interactions between the malignant cells and other cells of the tumor microenvironment. Moreover, CAFs actively participate in extracellular matrix deposition and remodeling, which are also related to disease progression.

In addition, endothelial cells help tumor cells communicate with surrounding areas by generating new vascular networks or modifying pre-existing vessels, thus conditioning tumor oxygen and nutrient supply. Since endothelial cells, as well as CAFs and tumor cells, affect immune cell recruitment within the tumor, it can be assumed that the tumor microenvironment will condition immune response. T-cell activation can end up either stimulating or inhibiting the immune system, depending on many factors, such as tumor antigen production, the regulation of inhibitory ligands, angiogenesis, CAF chemokine secretion, etc.

This Special Issue will include papers that investigate the different mechanisms related to the tumor microenvironment involved in CRC initiation, growth, and progression. Furthermore, experimental clinical and preclinical studies including bimolecular experiments to examine potential new approaches for increasing and improving CRC patient survival are welcome.

This Special Issue welcomes original research and review papers. Potential topics will include, but are not limited to:

  1. Molecular mechanisms of the tumor microenvironment cross-talk in CRC;
  2. Epigenetic regulation of the tumor microenvironment in CRC;
  3. Molecular imaging approaches to study the tumor microenvironment in CRC;
  4. Tumor biomarkers related to the tumor microenvironment in CRC patients;
  5. “Omics” studies of tumor microenvironment components in CRC;
  6. Therapeutic approaches of CRC patients based in the tumor microenvironment target.

Dr. Cristina Peña
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • colorectal cancer
  • tumor microenvironment
  • cancer-associated fibroblasts
  • endothelial cells
  • immune cells
  • extracellular matrix
  • tumor microenvironment biomarkers
  • tumor microenvironment-based clinical approaches

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

21 pages, 1590 KiB  
Review
Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
by Jian Lu, Marko Kornmann and Benno Traub
Int. J. Mol. Sci. 2023, 24(19), 14815; https://doi.org/10.3390/ijms241914815 - 01 Oct 2023
Cited by 4 | Viewed by 2197
Abstract
The epithelial–mesenchymal transition (EMT) is a cellular reprogramming process that occurs during embryonic development and adult tissue homeostasis. This process involves epithelial cells acquiring a mesenchymal phenotype. Through EMT, cancer cells acquire properties associated with a more aggressive phenotype. EMT and its opposite, [...] Read more.
The epithelial–mesenchymal transition (EMT) is a cellular reprogramming process that occurs during embryonic development and adult tissue homeostasis. This process involves epithelial cells acquiring a mesenchymal phenotype. Through EMT, cancer cells acquire properties associated with a more aggressive phenotype. EMT and its opposite, mesenchymal–epithelial transition (MET), have been described in more tumors over the past ten years, including colorectal cancer (CRC). When EMT is activated, the expression of the epithelial marker E-cadherin is decreased and the expression of the mesenchymal marker vimentin is raised. As a result, cells temporarily take on a mesenchymal phenotype, becoming motile and promoting the spread of tumor cells. Epithelial–mesenchymal plasticity (EMP) has become a hot issue in CRC because strong inducers of EMT (such as transforming growth factor β, TGF-β) can initiate EMT and regulate metastasis, microenvironment, and immune system resistance in CRC. In this review, we take into account the significance of EMT-MET in CRC and the impact of the epithelial cells’ plasticity on the prognosis of CRC. The analysis of connection between EMT and colorectal cancer stem cells (CCSCs) will help to further clarify the current meager understandings of EMT. Recent advances affecting important EMT transcription factors and EMT and CCSCs are highlighted. We come to the conclusion that the regulatory network for EMT in CRC is complicated, with a great deal of crosstalk and alternate paths. More thorough research is required to more effectively connect the clinical management of CRC with biomarkers and targeted treatments associated with EMT. Full article
(This article belongs to the Special Issue Tumor Microenvironment in Colorectal Cancer (Volume 2))
Show Figures

Figure 1

19 pages, 3922 KiB  
Review
The Diet as a Modulator of Tumor Microenvironment in Colorectal Cancer Patients
by Manuel Collado, Marién Castillo, Gemma Julia Muñoz de Mier, Carolina de la Pinta and Cristina Peña
Int. J. Mol. Sci. 2023, 24(8), 7317; https://doi.org/10.3390/ijms24087317 - 15 Apr 2023
Cited by 5 | Viewed by 2223
Abstract
Colorectal cancer (CRC) is one of the most common cancers in Western countries and remains the second most common cause of cancer death worldwide. Many studies show the importance of diet and lifestyle in the incidence of CRC, as well as in CRC [...] Read more.
Colorectal cancer (CRC) is one of the most common cancers in Western countries and remains the second most common cause of cancer death worldwide. Many studies show the importance of diet and lifestyle in the incidence of CRC, as well as in CRC prevention. However, this review summarizes those studies that analyze the impact of nutrition on tumor microenvironment modulation and cancer progression. We review the available information about the effects of specific nutrients on cancer cell progression and on the different cells within the tumor microenvironment. Diet and nutritional status in the clinical management of colorectal cancer patients are also analyzed. Finally, future perspectives and challenges are discussed, with a view to improving CRC treatments by employing nutritional approaches. These promise great benefits and will eventually improve CRC patients’ survival. Full article
(This article belongs to the Special Issue Tumor Microenvironment in Colorectal Cancer (Volume 2))
Show Figures

Graphical abstract

Back to TopTop